Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2017, Article ID 3076017, 6 pages
https://doi.org/10.1155/2017/3076017
Research Article

Isolated Ro52 Antibodies as Immunological Marker of a Mild Phenotype of Undifferentiated Connective Tissue Diseases

1Biochemistry Unit, Central Laboratory, Complejo Hospitalario Universitario de Canarias, Tenerife, Spain
2Immunology Unit, Central Laboratory, Complejo Hospitalario Universitario de Canarias, Tenerife, Spain
3Rheumatology Department, Complejo Hospitalario Universitario de Canarias, Tenerife, Spain

Correspondence should be addressed to Yvelise Barrios; moc.liamg@soirrab.esilevy

Received 11 November 2016; Accepted 29 December 2016; Published 22 January 2017

Academic Editor: Charles J. Malemud

Copyright © 2017 Ana Alonso-Larruga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mosca, C. Tani, S. Vagnani, L. Carli, and S. Bombardieri, “The diagnosis and classification of undifferentiated connective tissue diseases,” Journal of Autoimmunity, vol. 48-49, pp. 50–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Mosca, C. Tani, S. Vagnani, L. Carli, and S. Bombardieri, “Undiferentiated connective tissue diseases,” Autoimmunity Reviews, vol. 6, no. 1, pp. 1–4, 2006. View at Publisher · View at Google Scholar
  3. R. S. Panush, N. Kramer, and E. D. Rosenstein, “Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes,” Internet Monograph, UpToDate, 2013, http://www.uptodate.com/. View at Google Scholar
  4. M. Mosca, C. Tani, L. Carli, and S. Bombardieri, “Undifferentiated CTd: a wide spectrum of autoimmune diseases,” Best Practice and Research: Clinical Rheumatology, vol. 26, no. 1, pp. 73–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Ben-Chetrit, E. K. L. Chan, K. F. Sullivan, and E. M. Tan, “A 52-kD protein is a novel component of the SS-A/Ro antigenic particle,” Journal of Experimental Medicine, vol. 167, no. 5, pp. 1560–1571, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. D. B. Bloch, R. H. Shmerling, and M. P. Ramirez, The anti-Ro/SSA and anti-La/SSb antigen-antibody systems. [Internet monograph] UpToDate, 2013, http://www.uptodate.com/.
  7. M. Hudson, J. Pope, M. Mahler et al., “Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis,” Arthritis Research and Therapy, vol. 14, no. 2, article no. R50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Hervier, M. Rimbert, F. Colonna, M. A. Hamidou, and M. Audrain, “Clinical significance of anti-Ro/SSA-52 kDa antibodies—a retrospective monocentric study,” Rheumatology, vol. 48, no. 8, pp. 964–967, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. 1997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus Criterion, http://www.rheumatology.org/Practice/Clinical/Classification/Classification_Criteria_for_Other_Diseases/.
  10. S. C. Shiboski, C. H. Shiboski, L. A. Criswell et al., “American College of rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort,” Arthritis Care and Research, vol. 64, no. 4, pp. 475–487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Defendenti, F. Atzeni, M. F. Spina et al., “Clinical and laboratory aspects of Ro/SSA-52 autoantibodies,” Autoimmunity Reviews, vol. 10, no. 3, pp. 150–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Arthritis. Health information. Who is affected by Rheumatic Diseases? National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, https://www.niams.nih.gov/health_info/arthritis/arthritis_rheumatic.asp.
  13. Systemic Lupus Erythematosus. Medline Plus, http://www.nlm.nih.gov/medlineplus/ency/article/000435.htm.
  14. Sjögren Syndrome, Medline Plus, http://www.nlm.nih.gov/medlineplus/sjogrenssyndrome.html.
  15. I. Rua-Figueroa, J. Calvo, M. J. Cuadrado et al., Manual SER de Diagnóstico y Tratamiento de las Enfermedades Reumáticas Autoinmunes Sitémicas, Elsevier, 1st edition, 2014.
  16. G. Tchernev and C. E. Orfanos, “Antigen mimicry, epitope spreading and the pathogenesis of pemphigus,” Tissue Antigens, vol. 68, no. 4, pp. 280–286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. O. G. Carballo, C. A. Von Mühlen, R. Nakamura, I. García, and P. L. Carvalho, ATLAS. Anticuerpos Antinucleocitoplasmáticos (Hep-2), Talleres Gráficos MPS, 1st edition, 2006.
  18. K. E. E. Elagib, P. Tengnér, M. Levi et al., “Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjogren's syndrome,” Arthritis & Rheumatism, vol. 42, no. 11, pp. 2471–2481, 1999. View at Publisher · View at Google Scholar · View at Scopus